StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Guided Therapeutics's profit margin for the twelve months ending Jun 30, 2026 was -471.5%. For fiscal 2025 it was -416.7%, against -34528.6% the year before. The highest annual figure on record is 1782.5% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-416.7%+34111.9
FY2024Dec 31, 2024-34528.6%−30968.4
FY2023Dec 31, 2023-3560.2%+29832.1
FY2022Dec 31, 2022-33392.3%−30836.8
FY2021Dec 31, 2021-2555.6%−2282.0
FY2020Dec 31, 2020-273.5%+5062.6
FY2019Dec 31, 2019-5336.1%−7118.6
FY2018Dec 31, 20181782.5%+6166.1
FY2017Dec 31, 2017-4383.6%+12049.7
FY2015Dec 31, 2015-16433.3%−1228.7
FY2014Dec 31, 2014-15204.6%−14324.7
FY2013Dec 31, 2013-879.9%−749.5
FY2012Dec 31, 2012-130.4%+54.3
FY2011Dec 31, 2011-184.7%−100.1
FY2010Dec 31, 2010-84.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-206.4%−199.7
Q3 FY2025Sep 30, 2025-1236.7%−30.4
Q2 FY2025Jun 30, 2025-693.2%+2845.5
Q4 FY2024Dec 31, 2024-65200.0%−61250.0
Q1 FY2024Mar 31, 2024-6.7%+36726.6
Q4 FY2023Dec 31, 2023-1206.3%+17313.8
Q2 FY2023Jun 30, 2023-3538.6%+6601.4
Q1 FY2023Mar 31, 2023-3950.0%−3210.0
Q3 FY2022Sep 30, 2022-36733.3%−37091.2
Q2 FY2022Jun 30, 2022-18520.0%+33180.0
Q1 FY2022Mar 31, 2022-10140.0%−18804.0
Q4 FY2021Dec 31, 2021-740.0%−2785.5
Q3 FY2021Sep 30, 2021357.9%−6410.9
Q2 FY2021Jun 30, 2021-51700.0%−39100.0
Q4 FY2020Dec 31, 20208664.0%+274964.0
Q3 FY2020Sep 30, 20202045.5%+3239.9
Q4 FY2019Dec 31, 20196768.8%+13297.3
Q3 FY2019Sep 30, 2019-12600.0%+24700.0
Q2 FY2019Jun 30, 2019-266300.0%−309050.0
Q1 FY2019Mar 31, 2019-1194.4%−28244.4
Q4 FY2018Dec 31, 2018-6528.6%+1635.9
Q3 FY2018Sep 30, 2018-37300.0%−30133.3
Q2 FY2018Jun 30, 201842750.0%+43981.0
Q1 FY2018Mar 31, 201827050.0%+27559.5
Q4 FY2017Dec 31, 2017-8164.5%−7942.4
Q3 FY2017Sep 30, 2017-7166.7%–
Q2 FY2017Jun 30, 2017-1231.0%–
Q1 FY2017Mar 31, 2017-509.5%–
Q3 FY2016Sep 30, 2016-222.1%–

More Guided Therapeutics figures

See a number that looks wrong?